Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Zepbound: SURMOUNT-5 SURMOUNT-5 was a Phase 3b open-label clinical trial with 751 participants looking at the safety and efficacy of Zepbound (tirzepatide) compared to Wegovy (semaglutide) in adults with obesity, or overweight with at least one weight-related medical problem and without type 2 diabetes
Whether you need conservative care, minimally invasive treatment, or surgical intervention, were here to help you regain your comfort and confidence
It should not be self-injected or treated as a pharmacy prescription
Foundational research by Maquart et al
US$ 25.84
US$ 21.75
